These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 1695002

  • 1. [Phase II study with etoposide/vincristine in small cell bronchial cancer (extensive disease)].
    von Pawel J, Wilke H, Vallée D, Dimbeck H, Schmoll HJ.
    Pneumologie; 1990 Feb; 44 Suppl 1():582-3. PubMed ID: 1695002
    [Abstract] [Full Text] [Related]

  • 2. [Chemotherapy of small cell bronchial cancer with a combination of carboplatin, vincristine and etoposide].
    Gatzemeier U, Achterrath W, Heckmayr M, Hossfeld DK, Neuhauss R, Reck M, Zschaber R.
    Pneumologie; 1990 Feb; 44 Suppl 1():584-5. PubMed ID: 2164203
    [Abstract] [Full Text] [Related]

  • 3. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC, McCrystal MR, Christmas TI.
    N Z Med J; 1998 Nov 27; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [Abstract] [Full Text] [Related]

  • 4. Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: a prospective randomized phase III trial.
    Gatzemeier U, Pawel JV, Laumen R, Hossfeld DK, Neuhauss R.
    Semin Oncol; 1994 Jun 27; 21(3 Suppl 6):31-5. PubMed ID: 8052871
    [Abstract] [Full Text] [Related]

  • 5. [The effect of combination chemotherapy with cisplatin, vincristine, doxorubicin and etoposide (Tokushima-CODE: T-CODE) against lung cancer].
    Yanagawa H, Bando H, Takishita Y, Shinohara T, Tanaka H.
    Gan To Kagaku Ryoho; 1992 Aug 27; 19(9):1403-5. PubMed ID: 1323959
    [No Abstract] [Full Text] [Related]

  • 6. Phase II trial evaluating continuous infusion of etoposide, cisplatin, and hexamethylmelamine in extensive-disease small cell carcinoma of the lung.
    Remick SC, Neville AJ, Willson JK.
    Cancer Treat Rep; 1987 Jun 27; 71(6):575-80. PubMed ID: 3034422
    [Abstract] [Full Text] [Related]

  • 7. [Nerve conduction velocity following high-dose vincristine in the treatment of small cell bronchial cancer].
    Eich F, Emser W, Sybrecht GW.
    Pneumologie; 1990 Feb 27; 44 Suppl 1():574-5. PubMed ID: 2164202
    [Abstract] [Full Text] [Related]

  • 8. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Aamdal S, Norwegian Lung Cancer Study Group.
    Lung Cancer; 2005 May 27; 48(2):251-61. PubMed ID: 15829326
    [Abstract] [Full Text] [Related]

  • 9. [Chemotherapy of small cell lung cancer].
    Komiya T, Takada M.
    Gan To Kagaku Ryoho; 1996 Aug 27; 23(9):1116-23. PubMed ID: 8751797
    [Abstract] [Full Text] [Related]

  • 10. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.
    Reck M, von Pawel J, Macha HN, Kaukel E, Deppermann KM, Bonnet R, Ulm K, Hessler S, Gatzemeier U.
    Lung Cancer; 2006 Jul 27; 53(1):67-75. PubMed ID: 16713013
    [Abstract] [Full Text] [Related]

  • 11. Single-dose etoposide in combination with vincristine and doxorubicin in the treatment of small-cell lung cancer (SCLC).
    Timothy AR, Calman FM, Bateman NT, Farebrother M, Slevin ML, Bellamy D, Rubens RD, Costello J.
    Semin Oncol; 1985 Mar 27; 12(1 Suppl 2):45-7. PubMed ID: 2983435
    [Abstract] [Full Text] [Related]

  • 12. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
    Mok TS, Wong H, Zee B, Yu KH, Leung TW, Lee TW, Yim A, Chan AT, Yeo W, Chak K, Johnson P.
    Cancer; 2002 Oct 01; 95(7):1511-9. PubMed ID: 12237920
    [Abstract] [Full Text] [Related]

  • 13. [Cisplatin-Vepeside versus Endoxan-Vepeside in the treatment of small cell bronchial cancer. A randomized study].
    Heckmayr M, Gatzemeier U, Hossfeld DK, Koschel G, Thies F, Zschaber R.
    Pneumologie; 1990 Feb 01; 44 Suppl 1():256-7. PubMed ID: 2164193
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin, etoposide, and vincristine combination chemotherapy in the treatment of non-small cell lung cancer.
    Watanabe A, Ichiyama S, Shimokata K, Nagura E, Saito H, Saka H, Nomura F, Sakai S, Saito H.
    Nagoya J Med Sci; 1993 Mar 01; 55(1-4):41-6. PubMed ID: 8247105
    [Abstract] [Full Text] [Related]

  • 15. Cyclic alternating chemotherapy for small cell carcinoma of the lung.
    Murray N, Shah A, Wilson K, Goldie J, Voss N, Fryer C, Klimo P, Coy P, Hadzic E, Gudauskas G.
    Cancer Treat Rep; 1985 Nov 01; 69(11):1241-2. PubMed ID: 3004724
    [Abstract] [Full Text] [Related]

  • 16. Cisplatin and etoposide alternating with vincristine, doxorubicin and cyclophosphamide in patients with small cell lung cancer.
    Littlewood TJ, Smith AP, Anderson G, Chappell AG, James KW.
    Eur J Respir Dis; 1985 Oct 01; 67(4):294-300. PubMed ID: 3000808
    [Abstract] [Full Text] [Related]

  • 17. Ifosfamide, doxorubicin, vincristine, and etoposide in small cell lung cancer.
    Elisson LO, Ekberg L.
    Semin Oncol; 1995 Feb 01; 22(1 Suppl 2):15-7. PubMed ID: 7846536
    [Abstract] [Full Text] [Related]

  • 18. [The role of surgical treatment in the combination therapy of small cell lung cancer (SCLC)].
    Yamaguchi Y, Momiki S, Kimura H, Ogawa T, Baba M.
    Kyobu Geka; 1988 Mar 01; 41(3):184-9. PubMed ID: 2838669
    [No Abstract] [Full Text] [Related]

  • 19. [Multidisciplinary treatment for small cell lung cancer].
    Saijo N, Eguchi K, Shimizu E, Shinkai T, Tominaga K, Takahashi K, Sasaki Y, Seki S.
    Gan To Kagaku Ryoho; 1984 Mar 01; 11(3):474-9. PubMed ID: 6322700
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M, Erturk D.
    Saudi Med J; 2003 Jun 01; 24(6):628-31. PubMed ID: 12847592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.